Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

TKOMY or WRB: Which Is the Better Value Stock Right Now?
TKOMY or WRB: Which Is the Better Value Stock Right Now?

Investors interested in Insurance - Property and Casualty stocks are likely familiar with Tokio Marine Holdings Inc. (TKOMY) and W.R. Berkley (WRB). But which of these two stocks presents investors

PAHC vs. BSX: Which Stock Is the Better Value Option?
PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a

CCL or ATAT: Which Is the Better Value Stock Right Now?
CCL or ATAT: Which Is the Better Value Stock Right Now?

Investors with an interest in Leisure and Recreation Services stocks have likely encountered both Carnival (CCL) and Atour Lifestyle Holdings Limited Sponsored ADR (ATAT). But which of these two

IFS vs. AXP: Which Stock Is the Better Value Option?
IFS vs. AXP: Which Stock Is the Better Value Option?

Investors interested in stocks from the Financial - Miscellaneous Services sector have probably already heard of Intercorp Financial Services Inc. (IFS) and American Express (AXP). But which of

DE's H Series Sets New Industry Standard: Will It Lead the C&F Market?
DE's H Series Sets New Industry Standard: Will It Lead the C&F Market?

Deere & Company DE has raised the bar in forestry equipment with the launch of its H Series Forestry machines, boasting an industry-first innovation like enhanced hydraulic systems, advanced

RARE's GTX-102 Gets FDA's Breakthrough Status for Angelman Syndrome
RARE's GTX-102 Gets FDA's Breakthrough Status for Angelman Syndrome

Ultragenyx Pharmaceuticals RARE announced that the FDA has granted the Breakthrough Therapy designation to its investigational antisense oligonucleotide therapy, GTX-102 (apazunersen), to treat

Stellantis Recalls 250K Vehicles in the US Due to an Airbag Defect
Stellantis Recalls 250K Vehicles in the US Due to an Airbag Defect

Stellantis N.V. STLA is recalling 250,651 vehicles in the United States because of a defect in the side curtain airbags that may not be properly sealed, per the U.S. National Highway Traffic Safety

NU vs. DAVE: Which Fintech Stock Should Investors Back Right Now?
NU vs. DAVE: Which Fintech Stock Should Investors Back Right Now?

Both Nu Holdings NU and Dave DAVE are major players in the digital financial services sector. NU is a prominent digital bank serving more than 118 million customers across Brazil, Colombia and

C Clears 2025 Fed Stress Test: Make Investment or Still Wait?
C Clears 2025 Fed Stress Test: Make Investment or Still Wait?

Citigroup Inc. C has passed the Federal Reserve’s 2025 stress test. Post-clearing the stress test, C now has the flexibility to return excess capital to shareholders via dividends and share

5 Sector ETFs That Beat the Market in June
5 Sector ETFs That Beat the Market in June

Wall Street is set to wrap up one of the strongest monthly advances so far in 2025, fueled by optimism surrounding global trade and easing fears over tariffs. The S&P 500 and the Nasdaq Composite

Tesla's Model Y Completes First Human-Free Car Delivery
Tesla's Model Y Completes First Human-Free Car Delivery

Tesla, Inc. TSLA has achieved a breakthrough in autonomous vehicle technology by completing the world’s first driverless car delivery. A Model Y drove itself from Tesla’s Gigafactory in Austin, TX

Implied Volatility Surging for UFP Technologies Stock Options
Implied Volatility Surging for UFP Technologies Stock Options

Investors in UFP Technologies, Inc. UFPT need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $175.00 Put had some of the highest

Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates
Kewaunee Scientific Stock Soars 47% After Q4 Earnings Beat Estimates

Shares of Kewaunee Scientific Corporation KEQU have risen 47.1% since reporting results for the fourth quarter of fiscal 2025. This compares with the S&P 500 index’s 6.1% growth over the same time

Is the Options Market Predicting a Spike in Hayward Holdings Stock?
Is the Options Market Predicting a Spike in Hayward Holdings Stock?

Investors in Hayward Holdings, Inc. HAYW need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $07.50 Put had some of the highest

Can Deckers Offset Tariff Costs Through Pricing & Sourcing Shifts?
Can Deckers Offset Tariff Costs Through Pricing & Sourcing Shifts?

Deckers Outdoor Corporation DECK highlighted that recent changes in U.S. trade policies, particularly the introduction of higher tariffs, are expected to significantly impact its business. The

Do Options Traders Know Something About Sanmina Stock We Don't?
Do Options Traders Know Something About Sanmina Stock We Don't?

Investors in Sanmina Corporation SANM need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $50.00 Put had some of the highest

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
Why BigBear.ai Could Rally 100% and Catch Palantir Soon

Every investor is familiar with one of the most successful and widely followed stories in the market today, particularly in the world of aerospace and defense stocks. However, there is a new

Is Procter & Gamble Set to Shield Earnings From Global Volatility?
Is Procter & Gamble Set to Shield Earnings From Global Volatility?

The Procter & Gamble Company PG is not fully immune to global headwinds like currency swings, inflation, tariffs and potential trade tensions. Given its significant global foothold, the company is

Major Banks Pass 2025 Stress Test: Bigger Payouts in the Cards?
Major Banks Pass 2025 Stress Test: Bigger Payouts in the Cards?

The results of the much-awaited annual stress test are out. As expected, the 22 banks that were tested have easily passed this year’s annual health checkup, given that the 2025 scenario used to test

Do Options Traders Know Something About Navient Stock We Don't?
Do Options Traders Know Something About Navient Stock We Don't?

Investors in Navient Corporation NAVI need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 18, 2025 $07.50 Put had some of the highest

Vertiv's Liquid Cooling Stack Gaining Adoption: Will the Tech Deliver?
Vertiv's Liquid Cooling Stack Gaining Adoption: Will the Tech Deliver?

Vertiv VRT is expanding liquid cooling solutions across its AI infrastructure portfolio to accelerate deployment and support large-scale data center growth. These advanced thermal systems, including

Can the Share Buyback Act as a Catalyst for Vistra's Long-Term Growth?
Can the Share Buyback Act as a Catalyst for Vistra's Long-Term Growth?

Vistra Corp.’s VST aggressive share repurchase initiative is central to its long-term value creation strategy. Since November 2021, the company has repurchased shares worth $5.2 billion of its own

Constellation Brands Pre-Q1 Earnings: Are Trends Pointing to a Beat?
Constellation Brands Pre-Q1 Earnings: Are Trends Pointing to a Beat?

Constellation Brands, Inc. STZ is scheduled to release first-quarter fiscal 2026 results on July 1, 2025. The alcoholic beverage bigwig is expected to have recorded top and bottom-line declines in

Apogee Beats Q1 Earnings & Revenue Estimates, Hikes FY26 View
Apogee Beats Q1 Earnings & Revenue Estimates, Hikes FY26 View

Apogee Enterprises, Inc. APOG reported earnings per share (EPS) of 56 cents in first-quarter fiscal 2026 (ended May 31, 2025), surpassing the Zacks Consensus Estimate of 50 cents. The bottom line

Wall Street Set to Close Strong a Turbulent 1H 2025
Wall Street Set to Close Strong a Turbulent 1H 2025

It’s the final day of the first half of 2025, and market indexes are once again at all-time highs on the S&P 500 and Nasdaq, closing-in on the Dow and small-cap Russell 2000. We’re also roughly +20%